CTKB - CIK 0001831915
Cytek Biosciences, Inc. (CTKB) reported net income of -$66.54M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$66.54M | -1005.3% |
| FY 2024 | -$6.02M | +50.4% |
| FY 2023 | -$12.15M | -589.0% |
| FY 2022 | $2.48M | -17.9% |
| FY 2021 | $3.03M | -84.4% |
| FY 2020 | $19.41M | - |
Cytek Biosciences, Inc. (CTKB) reported net income of -$66.54M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2025, Cytek Biosciences, Inc.'s net income declined from $19.41M to -$66.54M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.